Varying effects of common tuberculosis drugs on enhancing clofazimine activity in vitro

Emerging Microbes & Infections (2017) 6, e28; doi:http://10.1038/emi.2017.24; published online 26 April 2017

[1]  J. Grosset,et al.  Clofazimine has delayed antimicrobial activity against Mycobacterium tuberculosis both in vitro and in vivo , 2017, The Journal of antimicrobial chemotherapy.

[2]  D. van Soolingen,et al.  Clofazimine Prevents the Regrowth of Mycobacterium abscessus and Mycobacterium avium Type Strains Exposed to Amikacin and Clarithromycin , 2015, Antimicrobial Agents and Chemotherapy.

[3]  W. Shi,et al.  Identification of novel mutations associated with clofazimine resistance in Mycobacterium tuberculosis. , 2015, The Journal of antimicrobial chemotherapy.

[4]  J. Grosset,et al.  Clofazimine shortens the duration of the first-line treatment regimen for experimental chemotherapy of tuberculosis , 2015, Proceedings of the National Academy of Sciences.

[5]  Ying Zhang,et al.  Mechanisms of Pyrazinamide Action and Resistance. , 2014, Microbiology spectrum.

[6]  S. Cole,et al.  Cross-Resistance between Clofazimine and Bedaquiline through Upregulation of MmpL5 in Mycobacterium tuberculosis , 2014, Antimicrobial Agents and Chemotherapy.

[7]  W. Shi,et al.  Mutations in panD encoding aspartate decarboxylase are associated with pyrazinamide resistance in Mycobacterium tuberculosis , 2013, Emerging Microbes & Infections.

[8]  H. Steel,et al.  Clofazimine: current status and future prospects. , 2012, The Journal of antimicrobial chemotherapy.

[9]  J. Winkler,et al.  Reduction of Clofazimine by Mycobacterial Type 2 NADH:Quinone Oxidoreductase , 2010, The Journal of Biological Chemistry.

[10]  A. Van Deun,et al.  Short, highly effective, and inexpensive standardized treatment of multidrug-resistant tuberculosis. , 2010, American journal of respiratory and critical care medicine.

[11]  I. Chopra,et al.  Anti-staphylococcal activity and mode of action of clofazimine. , 2004, The Journal of antimicrobial chemotherapy.

[12]  Ying Zhang,et al.  Mode of action of pyrazinamide: disruption of Mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. , 2003, The Journal of antimicrobial chemotherapy.

[13]  R. Anderson,et al.  Antimicrobial activities of clofazimine and B669 are mediated by lysophospholipids , 1992, Antimicrobial Agents and Chemotherapy.

[14]  V. Barry,et al.  A New Series of Phenazines (Rimino-Compounds) With High Antituberculosis Activity , 1957, Nature.

[15]  I. Chopra,et al.  Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections , 2010, Nature Reviews Microbiology.

[16]  H. Rieder,et al.  Highly Effective , and Inexpensive Standardized Treatment of Multidrug-resistant Tuberculosis , 2010 .